Mesenchymal Stem Cells and Diabetic Nephropathy
Bing Liu, Guanqiao You, Li-na Zhang, Lin Tao, Hui Chen, Feng-min Shao
Department of Nephrology, Henan Provincial People's Hospital, Zhengzhou, Henan 450003, China
【Abstract】 Mesenchymal stem cells (MSCs) are a class of self-renewing, multilineage differentiation potential, immune regulation and low immunogenic cells. MSCs are able to differentiate into osteoblasts, chondrocytes, adipocytes, muscle (tendon) cells, hepatocytes, neurons and other cells. Because of their immunomodulatory ability, capacity for self-renewal, and differentiation into mesodermal tissues, MSCs are described as new choice in the treatment of various diseases, including diabetes mellitus, diabetic nephropathy. In this article, we review the research progress for MSCs therapy in diabetes nephropathy.
[Bing Liu, Guanqiao You, Li-na Zhang, Lin Tao, Hui Chen, Feng-min Shao. Mesenchymal Stem Cells and Diabetic Nephropathy. Life Sci J 2013:10(1):3105-3107]. (ISSN: 1097-8135). http://www.lifesciencesite.com. 5
【Keywords】Mesenchymal stem cells; diabetes; diabetic nephropathy.